News Related to Lupus
-
Drug Shows Promise for Lupus Skin Conditions
Dec. 7, 2012 -- A drug related to thalidomide may be more potent and less toxic than thalidomide, which is often used to treat lupus skin conditions. In a small study from Spain, lupus patients showed dramatic improvements in skin lesions while taking the drug, lenalidomide (Revlimid), and most rela
Read Full Article -
Flesh-Eating Bacteria and Lupus
May 14, 2012 -- Infection with flesh-eating bacteria, a condition called called necrotizing fasciitis, has struck Aimee Copeland, a 24-year-old Georgia student who reportedly also has lupus. It's estimated that 5 million people worldwide, including 1.5 million Americans, have lupus. Are they at risk
Read Full Article -
New Guidelines for Kidney Disease Due to Lupus
May 3, 2012 -- When lupus attacks the kidneys, the damage can be life-threatening. Now, updated guidelines from the American College of Rheumatology are aimed at identifying kidney involvement in lupus early and treating it aggressively to stop this damage in its tracks. Systemic lupus erythematosus
Read Full Article -
Vitamin D Shows Early Promise Against Lupus
Nov. 8, 2011 (Chicago) -- In the first study of its kind, high doses of vitamin D were safe and appeared to temper some of the destructive immune system responses believed to cause lupus. The small, preliminary study did not look at whether skin rashes, fatigue, fever, and other symptoms of lupus ac
Read Full Article -
New Lupus Treatment Benlysta: FAQ
March 9, 2011 -- The FDA has approved Benlysta, the first new lupus treatment in 50 years. An FDA advisory panel last November voted 13-2 in favor of approval. But the panel noted that Benlysta is no wonder drug. Overall, it offered a modest benefit. Only 30% of patients who took the drug in clinica
Read Full Article -
New Lupus Drug Benlysta Approved
March 9, 2011 -- The FDA has approved Benlysta, the first new lupus drug since 1955. Benlysta is approved for the treatment of patients with active, autoantibody-positive lupus who are getting standard therapy. Standard therapy includes corticosteroids, antimalarial drugs, immunosuppressive agents,
Read Full Article -
Scientists Make Discoveries in the Biology of Lupus
March 9, 2011 -- Researchers think they may have discovered the mechanism that drives the body’s attack on its own cells and tissues in the autoimmune disease lupus. Two new studies published in the journal Science Translational Medicine point to a cycle of cell death and chronic inflammation involv
Read Full Article -
FDA Advisory Panel Backs New Lupus Drug
Nov. 16, 2010 -- At the end of a day of often emotional testimony, an FDA advisory panel overwhelmingly voted to recommend the approval of a new drug for the treatment of systemic lupus. If the FDA follows the panel’s advice, the drug, belimumab, will be the first drug approved in more than 50 years
Read Full Article -
Benlysta Shows Promise for Lupus
Nov. 15, 2010 (Atlanta) -- People with lupus given the first in a new class of experimental drugs that target the disease process did better than patients given standard treatment, according to one-year results of a large clinical trial. Longer follow-up of the patients suggests that over time, the
Read Full Article -
Statins May Not Benefit Kids With Lupus
Nov. 9, 2010 (Atlanta) -- The routine use of cholesterol-lowering statin drugs in children and adolescents with systemic lupus is not warranted, a new study suggests. Researchers say the findings surprised them, as children with systemic lupus are at increased risk of early-onset atherosclerosis tha
Read Full Article
Today in Lupus
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.